A new scientific event in Gothenburg

Life Science Sweden is holding an event in Gothenburg for the first time.

Moderna develops mRNA vaccine against norovirus

A highly anticipated vaccine is in late clinical evaluation and could be ready for approval within a couple of years. The target is the norovirus, often called ...

Norwegian cancer research companies merge

The Norwegian companies Ultimovacs and Zelluna Immunotherapy plan to merge. At the same time, it is made clear that Ultimovacs' CEO is leaving the company.

Anna Törner: ”If I fall seriously ill, I’ll move to Finland”

”It is both undignified and undemocratic that cancer patients must travel to Finland to uphold a façade of fairness that does not truly exist”, Anna Törner writes in a column.

Career coach on salaries: “There is no right or wrong”

What is a reasonable salary for my job? It's a question we all ask ourselves. But how important is a higher salary really? Career coach Tina Persson believes th...

KI-forskare har upptäckt biomarkörer för postcovid

Forskare vid Karolinska institutet har i en ny studie identifierat en uppsättning proteiner i blod hos personer med långvariga besvär av postcovid.

Scale Up Your Image Analysis

ZEISS arivis Hub for accelerated analysis and faster results.

RegFile AB

Samuel Lagercrantz: “Companies that do this successfully will take the lead”

The development of new medicines and medical technologies should not focus too narrowly on prolonging life. It is equally important to develop treatments that r...

ZEISS Quality Innovations at CONTROL

May 6-9, 2025 in Stuttgart.

Mercodia AB

Optimize Courier SUPPLIERS (DISTRIBUTORS)

Explore our tailored program for Control 2025

Choose an innovation tour, or join our industry-specific guided tours.

Non-destructive testing and assembly control

Assess complete assembly.

Investment CEO: “The Nordics are outstanding in creating successful medtech companies”

Since the beginning of last month, Susanna Francke Rodau has been a partner and the new CEO of Segulah Medical Acceleration, which invests in medical technology...

AZ gets approval for drug targeting rare disease – it may reduce cortisone dependence

AstraZeneca’s drug Fasenra gets an expanded indication in the EU and is now approved as a treatment for the rare autoimmune disease known as Churg-Strauss syndrome.

Speed meets precision for high-density components

ZEISS METROTOM 800 320 kV.

High-performance Slide Scanner for Fluorescence, Brightfield and Polarization

ZEISS Axioscan 7.

Lonza

ProPharma

SGS Fimko Ltd.

Fundamental Aspects of Airy Disk Patterns

Knowledge Article from ZEISS.

Hon är ny vd för CSL Behring

Helena Bragd är sedan början på januari ny Nordic General Manager för biotechbolaget CSL Behring samt vd för CSL Behring AB.

QPS Netherlands B.V